Repository logo
 

IL-13Rα2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses.

Published version
Peer-reviewed

Change log

Authors

Lee, Chang-Min 
He, Chuan Hua 
Nour, Adel M 
Zhou, Yang 
Ma, Bing 

Abstract

Recent studies demonstrated that chitinase 3-like-1 (Chi3l1) binds to and signals via IL-13Rα2. However, the mechanism that IL-13Rα2 uses to mediate the effects of Chi3l1 has not been defined. Here, we demonstrate that the membrane protein, TMEM219, is a binding partner of IL-13Rα2 using yeast two-hybrid, co-immunoprecipitation, co-localization and bimolecular fluorescence complementation assays. Furthermore, fluorescence anisotropy nanodisc assays revealed a direct physical interaction between TMEM219 and IL-13Rα2-Chi3l1 complexes. Null mutations or siRNA silencing of TMEM219 or IL-13Rα2 similarly decreased Chi3l1-stimulated epithelial cell HB-EGF production and macrophage MAPK/Erk and PKB/Akt activation. Null mutations of TMEM219 or IL-13Rα2 also phenocopied one another as regards the ability of Chi3l1 to inhibit oxidant-induced apoptosis and lung injury, promote melanoma metastasis and stimulate TGF-β1. TMEM219 also contributed to the decoy function of IL-13Rα2. These studies demonstrate that TMEM219 plays a critical role in Chi3l1-induced IL-13Rα2 mediated signalling and tissue responses.

Description

Keywords

Animals, Apoptosis, Cell Line, Tumor, Chitinase-3-Like Protein 1, Heparin-binding EGF-like Growth Factor, Humans, Interleukin-13 Receptor alpha2 Subunit, Lung Injury, Lung Neoplasms, MAP Kinase Signaling System, Melanoma, Experimental, Membrane Proteins, Mice, Inbred C57BL, Neoplasm Metastasis, Proto-Oncogene Proteins c-akt, Transforming Growth Factor beta1, Two-Hybrid System Techniques, Wnt Signaling Pathway

Journal Title

Nat Commun

Conference Name

Journal ISSN

2041-1723
2041-1723

Volume Title

7

Publisher

Springer Science and Business Media LLC
Sponsorship
Wellcome Trust (101908/Z/13/Z)
National Institutes of Health (Grant IDs: R01 HL093017, U01 HL108638, R01 HL115813), Korea Drug Development Fund (Grant ID: KDDF-20132-11), Ministry of Education of Korea (Basic Science Research Program through the National Research Foundation of Korea (NRF-2012R1A6A3A03040533))